Literature DB >> 21481844

D-cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disorders.

Meera E Modi1, Larry J Young.   

Abstract

BACKGROUND: There are no drugs that specifically target the social deficits of autism spectrum disorders (ASD). This may be due to a lack of behavioral paradigms in animal models relevant to ASD. Partner preference formation in the prairie vole represents a social cognitive process involving socially reinforced learning. D-cycloserine (DCS) is a cognitive enhancer that acts at the N-methyl-D-aspartate receptor to promote learning. If DCS enhances socially reinforced learning in the partner preference paradigm, it may be useful in combination with behavioral therapies for enhancing social functioning in ASD.
METHODS: Female prairie and meadow voles were given DCS either peripherally or directly into one of three brain regions: nucleus accumbens, amygdala, or caudate putamen. Subjects were then cohabited with a male vole under conditions that do not typically yield a partner preference. The development of a preference for that stimulus male vole over a novel male vole was assessed using a partner preference test.
RESULTS: A low dose of DCS administered peripherally enhanced preference formation in prairie voles but not meadow voles under conditions in which it would not otherwise occur. These effects were replicated in prairie voles by microinfusions of DCS into the nucleus accumbens, which is involved in reinforcement learning, and the amygdala, which is involved in social information processing.
CONCLUSIONS: Partner preference in the prairie vole may provide a behavioral paradigm with face, construct, and predictive validity for identifying prosocial pharmacotherapeutics. D-cycloserine may be a viable treatment strategy for social deficits of ASD when paired with social behavioral therapy.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481844      PMCID: PMC3164818          DOI: 10.1016/j.biopsych.2011.01.026

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  57 in total

Review 1.  Psychotherapy for obsessive-compulsive disorder.

Authors:  Eric A Storch; Amy Mariaskin; Tanya K Murphy
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

2.  Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism.

Authors:  Suma Jacob; Camille W Brune; C S Carter; Bennett L Leventhal; Catherine Lord; Edwin H Cook
Journal:  Neurosci Lett       Date:  2007-02-03       Impact factor: 3.046

3.  Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze.

Authors:  R Pussinen; J Sirviö
Journal:  J Psychopharmacol       Date:  1999       Impact factor: 4.153

Review 4.  Behavioural phenotyping assays for mouse models of autism.

Authors:  Jill L Silverman; Mu Yang; Catherine Lord; Jacqueline N Crawley
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

5.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

6.  A pilot study of D-cycloserine in subjects with autistic disorder.

Authors:  David J Posey; Deborah L Kem; Naomi B Swiezy; Thayne L Sweeten; Ryan E Wiegand; Christopher J McDougle
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

7.  A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families.

Authors:  Joe A Hettinger; Xudong Liu; Charles E Schwartz; Ron C Michaelis; Jeanette J A Holden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-07-05       Impact factor: 3.568

8.  A common variant in DRD3 receptor is associated with autism spectrum disorder.

Authors:  Mariken de Krom; Wouter G Staal; Roel A Ophoff; Judith Hendriks; Jan Buitelaar; Barbara Franke; Maretha V de Jonge; Patrick Bolton; David Collier; Sarah Curran; Herman van Engeland; Jan M van Ree
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

9.  Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles.

Authors:  Y Liu; Z X Wang
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Authors:  Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

View more
  21 in total

1.  RNAi knockdown of oxytocin receptor in the nucleus accumbens inhibits social attachment and parental care in monogamous female prairie voles.

Authors:  Alaine C Keebaugh; Catherine E Barrett; Jamie L Laprairie; Jasmine J Jenkins; Larry J Young
Journal:  Soc Neurosci       Date:  2015-05-07       Impact factor: 2.083

2.  Activation of μ-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles.

Authors:  James P Burkett; Lauren L Spiegel; Kiyoshi Inoue; Anne Z Murphy; Larry J Young
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

3.  TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.

Authors:  C Kağan Gürkan; Randi J Hagerman
Journal:  Res Autism Spectr Disord       Date:  2012-10-01

Review 4.  The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.

Authors:  Meera E Modi; Larry J Young
Journal:  Horm Behav       Date:  2011-12-20       Impact factor: 3.587

Review 5.  Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date.

Authors:  Lawrence K Fung; Antonio Y Hardan
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

Review 6.  Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.

Authors:  Tatiana M Kazdoba; Prescott T Leach; Mu Yang; Jill L Silverman; Marjorie Solomon; Jacqueline N Crawley
Journal:  Curr Top Behav Neurosci       Date:  2016

7.  Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles.

Authors:  Karen L Bales; Allison M Perkeybile; Olivia G Conley; Meredith H Lee; Caleigh D Guoynes; Griffin M Downing; Catherine R Yun; Marjorie Solomon; Suma Jacob; Sally P Mendoza
Journal:  Biol Psychiatry       Date:  2012-10-16       Impact factor: 13.382

Review 8.  The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.

Authors:  James P Burkett; Larry J Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

9.  Variation in vasopressin receptor (Avpr1a) expression creates diversity in behaviors related to monogamy in prairie voles.

Authors:  Catherine E Barrett; Alaine C Keebaugh; Todd H Ahern; Caroline E Bass; Ernest F Terwilliger; Larry J Young
Journal:  Horm Behav       Date:  2013-01-28       Impact factor: 3.587

10.  Social Communication is an Emerging Target for Pharmacotherapy in Autism Spectrum Disorder - A Review of the Literature on Potential Agents.

Authors:  Danielle A Baribeau; Evdokia Anagnostou
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.